| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anaesthesia, Hôtel-Dieu, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Address correspondence to: François Donati PhD MD FRCPC, Département d'anesthésie, Centre Hospitalier de l'Université de Montréal, Hôtel- Dieu, 3840, rue Saint Urbain, Montréal, Québec, H2W 1T8 Canada. Phone: 514-843-2611 X 4636; Fax: 514-543-2690; E-mail: donatif{at}medclin.umontreal.ca
Purpose: Mivacurium-rocuronium combinations have been demonstrated to be more potent than either drug given alone. Combinations were compared with mivacurium and rocuronium, with respect to onset, intubating conditions, and duration of action in young and elderly adults.
Methods: Fentanyl-propofol-N2O-isoflurane anesthesia was given to ASA I and II adults aged 18-65 yr (45 patients) and over 66 yr (45 patients). In this blinded randomized study, we compared accelerographic adductor pollicis response and visual assessment of response to facial nerve stimulation after 0.25 mgkg1 mivacurium, 0.6 mgkg1 rocuronium, and a combination of 0.08 mgkg1 mivacurium plus 0.2 mgkg1 rocuronium. Intubating conditions at 2.5 min were rated as excellent, good, fair or poor.
Results: Onset times were similar for all drugs regimens and for both age groups (204-276 sec at the thumb; 142-196 sec at the eye) (P < 0.05 between muscles). Intubating conditions were similar in all groups, and rated good or excellent, except in two subjects. In young patients duration to 25% recovery was longer (P < 0.05) for rocuronium (mean ± SD) (39 ± 11 min) than for either mivacurium (23 ± 6 min), or the combination (27 ± 7 min). Duration was prolonged in the elderly for rocuronium (54 ± 17 min), and the combination ( 35 ± 11 min), but not for mivacurium (24 ± 6 min).
Conclusions: Mivacurium-rocuronium combinations yield onset times and intubating conditions similar to either parent agent with only two thirds as much total drug. Duration for such a mixture is similar to that of mivacurium in young adults and slightly prolonged in the elderly.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |